Metformin Mitigates Bevacizumab-Evoked Endothelial Dysfunction through Activating MEK/ERK and PI3K/AKT Pathways
Tohoku J Exp Med
.
2024 Dec 26.
doi: 10.1620/tjem.2024.J147.
Online ahead of print.
Authors
Bing Liu
1
2
,
Ruoyu Deng
3
,
Zhenzhen Yang
4
,
Dong Zhou
5
Affiliations
1
Department of Pulmonary and Critical Care Medicine, Zhongnan Hospital of Wuhan University.
2
Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences.
3
Health Management, University of Montpellier.
4
Undergraduate School of Medical Business, Guangdong Pharmaceutical University.
5
Shanghai Institute of Organic Chemistry, CAS.
PMID:
39721678
DOI:
10.1620/tjem.2024.J147
No abstract available